S&P 500   4,074.81 (-0.13%)
DOW   34,316.19 (-0.79%)
QQQ   292.96 (-0.14%)
AAPL   147.96 (-0.05%)
MSFT   253.20 (-0.76%)
META   119.69 (+1.35%)
GOOGL   101.08 (+0.09%)
AMZN   96.30 (-0.25%)
TSLA   194.98 (+0.14%)
NVDA   169.61 (+0.22%)
NIO   12.30 (-3.76%)
BABA   86.15 (-1.61%)
AMD   76.98 (-0.84%)
T   19.19 (-0.47%)
MU   55.90 (-3.04%)
CGC   3.68 (+1.66%)
F   14.11 (+1.51%)
GE   85.25 (-0.84%)
DIS   97.76 (-0.11%)
AMC   8.55 (+18.26%)
PYPL   78.45 (+0.05%)
PFE   50.52 (+0.78%)
NFLX   315.01 (+3.10%)
S&P 500   4,074.81 (-0.13%)
DOW   34,316.19 (-0.79%)
QQQ   292.96 (-0.14%)
AAPL   147.96 (-0.05%)
MSFT   253.20 (-0.76%)
META   119.69 (+1.35%)
GOOGL   101.08 (+0.09%)
AMZN   96.30 (-0.25%)
TSLA   194.98 (+0.14%)
NVDA   169.61 (+0.22%)
NIO   12.30 (-3.76%)
BABA   86.15 (-1.61%)
AMD   76.98 (-0.84%)
T   19.19 (-0.47%)
MU   55.90 (-3.04%)
CGC   3.68 (+1.66%)
F   14.11 (+1.51%)
GE   85.25 (-0.84%)
DIS   97.76 (-0.11%)
AMC   8.55 (+18.26%)
PYPL   78.45 (+0.05%)
PFE   50.52 (+0.78%)
NFLX   315.01 (+3.10%)
S&P 500   4,074.81 (-0.13%)
DOW   34,316.19 (-0.79%)
QQQ   292.96 (-0.14%)
AAPL   147.96 (-0.05%)
MSFT   253.20 (-0.76%)
META   119.69 (+1.35%)
GOOGL   101.08 (+0.09%)
AMZN   96.30 (-0.25%)
TSLA   194.98 (+0.14%)
NVDA   169.61 (+0.22%)
NIO   12.30 (-3.76%)
BABA   86.15 (-1.61%)
AMD   76.98 (-0.84%)
T   19.19 (-0.47%)
MU   55.90 (-3.04%)
CGC   3.68 (+1.66%)
F   14.11 (+1.51%)
GE   85.25 (-0.84%)
DIS   97.76 (-0.11%)
AMC   8.55 (+18.26%)
PYPL   78.45 (+0.05%)
PFE   50.52 (+0.78%)
NFLX   315.01 (+3.10%)
S&P 500   4,074.81 (-0.13%)
DOW   34,316.19 (-0.79%)
QQQ   292.96 (-0.14%)
AAPL   147.96 (-0.05%)
MSFT   253.20 (-0.76%)
META   119.69 (+1.35%)
GOOGL   101.08 (+0.09%)
AMZN   96.30 (-0.25%)
TSLA   194.98 (+0.14%)
NVDA   169.61 (+0.22%)
NIO   12.30 (-3.76%)
BABA   86.15 (-1.61%)
AMD   76.98 (-0.84%)
T   19.19 (-0.47%)
MU   55.90 (-3.04%)
CGC   3.68 (+1.66%)
F   14.11 (+1.51%)
GE   85.25 (-0.84%)
DIS   97.76 (-0.11%)
AMC   8.55 (+18.26%)
PYPL   78.45 (+0.05%)
PFE   50.52 (+0.78%)
NFLX   315.01 (+3.10%)
NASDAQ:EYES

Second Sight Medical Products - EYES Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$4.11
$13.05
52-Week Range
N/A
Volume
36,800 shs
Average Volume
132,982 shs
Market Capitalization
$54.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EYES stock logo

About Second Sight Medical Products (NASDAQ:EYES) Stock

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Receive EYES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter.

EYES Stock News Headlines

Vivani Medical Inc
EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.
See More Headlines

Receive EYES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter.

EYES Company Calendar

Last Earnings
6/29/2020
Today
12/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Electromedical Equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EYES
Employees
15
Year Founded
N/A

Profitability

Net Income
$-8,920,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.38 million
Book Value
$4.80 per share

Miscellaneous

Free Float
6,935,000
Market Cap
$54.38 million
Optionable
Optionable
Beta
2.55

Key Executives

  • Mr. Scott Dunbar (Age 64)
    Acting Chief Exec. Officer
    Comp: $301.39k
  • Mr. Edward Jonathon Sedo (Age 66)
    Acting Chief Accounting Officer, Principal Financial Officer & Controller
    Comp: $199.18k
  • Mr. Edward David Randolph (Age 64)
    Chief Operating Officer
    Comp: $366.44k
  • Gunnar Bjorg
    Founder
  • Ms. Lisa M. Wilson (Age 57)
    Founder & Pres of In-Site Communications and Investor Relations for Second Sight













EYES Stock - Frequently Asked Questions

How were Second Sight Medical Products' earnings last quarter?

Second Sight Medical Products, Inc. (NASDAQ:EYES) posted its quarterly earnings data on Monday, June, 29th. The medical device company reported ($1.71) earnings per share for the quarter, missing analysts' consensus estimates of ($1.23) by $0.48.

When did Second Sight Medical Products' stock split?

Shares of Second Sight Medical Products reverse split on the morning of Friday, August 19th 2022. The 1-3 reverse split was announced on Friday, August 19th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What is Will McGuire's approval rating as Second Sight Medical Products' CEO?

5 employees have rated Second Sight Medical Products Chief Executive Officer Will McGuire on Glassdoor.com. Will McGuire has an approval rating of 57% among the company's employees. This puts Will McGuire in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Second Sight Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Second Sight Medical Products investors own include Zynerba Pharmaceuticals (ZYNE), Adaptimmune Therapeutics (ADAP), Cara Therapeutics (CARA), VBI Vaccines (VBIV), Shopify (SHOP), Corbus Pharmaceuticals (CRBP), Sorrento Therapeutics (SRNE), Ekso Bionics (EKSO) and OPKO Health (OPK).

When did Second Sight Medical Products IPO?

(EYES) raised $32 million in an IPO on Wednesday, November 19th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. MDB Capital Group, LLC served as the underwriter for the IPO.

What is Second Sight Medical Products' stock symbol?

Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."

Who are Second Sight Medical Products' major shareholders?

Second Sight Medical Products' stock is owned by many different institutional and retail investors. Top institutional shareholders include Cutler Group LLC CA (0.00%). Insiders that own company stock include Gregg Williams and Jonathan Will Mcguire.
View institutional ownership trends
.

How much money does Second Sight Medical Products make?

Second Sight Medical Products (NASDAQ:EYES) has a market capitalization of $0.00 and generates $3.38 million in revenue each year.

How can I contact Second Sight Medical Products?

Second Sight Medical Products' mailing address is 12744 SAN FERNANDO ROAD SUITE 400, SYLMAR CA, 91342. The official website for the company is www.secondsight.com. The medical device company can be reached via phone at (818) 833-5000, via email at investors@secondsight.com, or via fax at 818-833-5067.

This page (NASDAQ:EYES) was last updated on 12/1/2022 by MarketBeat.com Staff